Moderna applies to FDA for authorization of COVID-19 vaccine

Pharmaceutical company Moderna on Monday applied to the US Food and Drug Administration for authorization of its COVID-19 vaccine, CNN reports.

The company asked the FDA to review an expanded data set showing the vaccine is 94.1% effective at preventing COVID-19 and 100% effective at preventing severe cases of the disease.